alfapump System
Device Treatment of recurrent or refractory ascites due to liver cirrhosis
PDI 07640168020507
General payments
$8,505
Research payments
$285,536
Through program year 2025, $8,505 in general payments and $285,536 in research payments were reported against alfapump System (Treatment of recurrent or refractory ascites due to liver cirrhosis).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $8,505 | 42 |
| 2025 | Research | $285,536 | 8 |
Breakdown
The top 5 of 36 recipients; each share is of general payments naming this product in 2025.
The top 5 of 8 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 10 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
42 general · 8 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.